Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

62.1K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.1K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

572
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
572

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and genetic basis for broad antibody recognition of a protective epitope on orthomarburgvirus GP2.

Cell reports·2026
Same author

2D Magnetic Materials for Sensor Technologies.

Sensors (Basel, Switzerland)·2026
Same author

Dynamic <i>S</i>-Acylation of GSDMA Regulates Pyroptosis.

ACS chemical biology·2026
Same author

TEpiNom: A computational framework integrating population data to prioritize Plasmodium falciparum T cell epitopes.

Vaccine·2026
Same author

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Nature communications·2026
Same author

Substrate specificity in a designed RAS-targeting protease is coupled to active site and distal motions.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 25, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development.

Brian G Pierce1,2, Nathaniel Felbinger1,2, Matthew Metcalf1,2

  • 1Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.

Viruses
|May 25, 2024
PubMed
Summary
This summary is machine-generated.

Developing an effective Hepatitis C virus (HCV) vaccine is crucial. Recent advances focus on the E1E2 glycoprotein antigen and nanoparticle delivery systems to overcome viral diversity and improve immune responses for a broadly neutralizing vaccine.

Keywords:
HCV E1E2nanoparticlesstructurevaccine

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.1K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K

Related Experiment Videos

Last Updated: Jun 25, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.1K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Hepatitis C virus (HCV) poses a significant global health burden, causing chronic liver disease and cancer.
  • Over 58 million people are chronically infected, with 1.5 million new infections annually, highlighting the urgent need for an effective vaccine.
  • HCV's high variability and immune evasion mechanisms present formidable challenges for vaccine development.

Purpose of the Study:

  • To review recent advances in understanding the Hepatitis C virus E1E2 heterodimeric structure.
  • To explore the potential of multivalent nanoparticle-based vaccines for eliciting broadly neutralizing antibodies (bnAbs).
  • To address the challenges of low antigen immunogenicity and viral diversity in HCV vaccine design.

Main Methods:

  • Focus on structure-based vaccine design using atomic-level resolution of E1E2 glycoprotein.
  • Investigate nanoparticle vaccine platforms for multivalent antigen presentation.
  • Analyze strategies to elicit robust humoral and cellular immune responses against conserved E1E2 antigenic domains.

Main Results:

  • Advances in understanding E1E2 structure facilitate rational vaccine design.
  • Nanoparticle vaccines offer a promising platform for controlled, multivalent antigen delivery.
  • Improved antigen presentation may overcome low immunogenicity and elicit broadly neutralizing antibodies.

Conclusions:

  • Developing a multivalent nanoparticle-based HCV E1E2 vaccine is a promising strategy.
  • Addressing viral diversity and immune escape is key to an effective HCV vaccine.
  • Structure-guided design and advanced delivery platforms are crucial for successful HCV vaccine development.